Adrian Felipe Hernandez, MD

Professor of Medicine
Member in the Duke Clinical Research Institute
Campus mail 200 Trent Drive, Davison Building (Suite 120), Durham, NC 27710
Phone (919) 668-7515
Email address adrian.hernandez@duke.edu
In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2000 - 2004
  • Medical Resident, Medicine, University of California, San Francisco, School of Medicine, 1997 - 2000
  • M.D., University of Texas at Dallas, 1997

Publications

Fudim, Marat, Kishan S. Parikh, Allison Dunning, Adam D. DeVore, Robert J. Mentz, Phillip J. Schulte, Paul W. Armstrong, et al. “Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)..” The American Journal of Cardiology 122, no. 9 (November 2018): 1506–12. https://doi.org/10.1016/j.amjcard.2018.07.023.

PMID
30172362
Full Text

Voors, Adriaan A., Sanjiv J. Shah, Jeroen J. Bax, Javed Butler, Mihai Gheorghiade, Adrian F. Hernandez, Dalane W. Kitzman, et al. “Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction..” European Journal of Heart Failure 20, no. 11 (November 2018): 1601–10. https://doi.org/10.1002/ejhf.1295.

PMID
30225882
Full Text

Borlaug, Barry A., Kevin J. Anstrom, Gregory D. Lewis, Sanjiv J. Shah, James A. Levine, Gabe A. Koepp, Michael M. Givertz, et al. “Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial..” Jama 320, no. 17 (November 2018): 1764–73. https://doi.org/10.1001/jama.2018.14852.

PMID
30398602
Full Text

Mentz, Robert J., Vivian P. Thompson, David Aguilar, Jasmine Choi, Stephanie M. Gustavson, Nayyar Iqbal, Alice P. Kong, et al. “Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease..” Circulation 138, no. 22 (November 2018): 2576–78. https://doi.org/10.1161/circulationaha.118.036811.

PMID
30571356
Full Text

Wangqin, Runqi, Daniel T. Laskowitz, Yongjun Wang, Zixiao Li, Yilong Wang, Liping Liu, Li Liang, et al. “International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines--Stroke Program..” J Am Heart Assoc 7, no. 20 (October 16, 2018). https://doi.org/10.1161/JAHA.118.010623.

PMID
30371291
Full Text

Hernandez, Adrian F., Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel P. Jones, Lawrence A. Leiter, et al. “Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial..” Lancet (London, England) 392, no. 10157 (October 2, 2018): 1519–29. https://doi.org/10.1016/s0140-6736(18)32261-x.

PMID
30291013
Full Text

Reed, S. D., Y. Li, H. Dakin, F. Becker, J. Leal, S. M. Gustavson, B. Kartman, et al. “Impact of exenatide on medical costs and health utilities in type 2 diabetes: experience from EXSCEL.” In Diabetologia, 61:S426–S426. SPRINGER, 2018.

Scholars@Duke

Becker, F., H. Dakin, S. D. Reed, Y. Li, J. Leal, S. M. Gustavson, B. Kartman, et al. “Lifetime cost-effectiveness simulation of exenatide once-weekly in type 2 diabetes: evidence from the EXSCEL trial.” In Diabetologia, 61:S366–S366. SPRINGER, 2018.

Scholars@Duke

Buse, J. B., M. A. Bethel, R. A. Patel, S. R. Stevens, S. M. Gustavson, Y. Lokhnygina, A. F. Hernandez, and R. R. Holman. “Potential impact of differential drop-in of open-label diabetes medications in EXSCEL.” In Diabetologia, 61:S21–22. SPRINGER, 2018.

Scholars@Duke

Katona, B., M. A. Bethel, R. Patel, V. P. Thompson, S. M. Gustavson, P. Ohman, N. Iqbal, J. B. Buse, A. F. Hernandez, and R. R. Holman. “Changes in serum calcitonin concentrations and incidence of adjudicated medullary thyroid carcinoma in the EXenatide Study of Cardiovascular Event Lowering (EXSCEL).” In Diabetologia, 61:S376–S376. SPRINGER, 2018.

Scholars@Duke

Pages